Guidelines on the treatment of acute myeloid leukemia: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associação Médica Brasileira - 2015.

about

Guidelines on the treatment of acute myeloid leukemia: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: Project guidelines: Associação Médica Brasileira - 2015.

Item

http://www.wikidata.org/entity/Q38916984

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Guidelines on the treatment of ...... ação Médica Brasileira - 2015.

@en

type

Item

label

Guidelines on the treatment of ...... ação Médica Brasileira - 2015.

@en

prefLabel

Guidelines on the treatment of ...... ação Médica Brasileira - 2015.

@en

P1476

Guidelines on the treatment of ...... ação Médica Brasileira - 2015.

@en

P2093

Evandro Maranhão Fagundes

http://www.w3.org/2001/XMLSchema#string

Katia Borgia Barbosa Pagnano

http://www.w3.org/2001/XMLSchema#string

Maria de Lourdes Lopes Ferrari Chauffaille

http://www.w3.org/2001/XMLSchema#string

Rosane Bittencourt

http://www.w3.org/2001/XMLSchema#string

Teresa Cristina Bortolheiro

http://www.w3.org/2001/XMLSchema#string

Wanderley Marques Bernardo

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: ...

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

A randomized study of high-dose cytarabine in induction in acute myeloid leukemia

Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.

Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93. AML-BFM Study Group.

Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial.

MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin.

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial.

A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group.

P304

58-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BJHH.2016.01.001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eduardo Magalhães Rego

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26969776

http://www.w3.org/2001/XMLSchema#string

P932

4786761

http://www.w3.org/2001/XMLSchema#string